The IPAD Cohort Study: Insomnia and Positive Airway Pressure Adherence in Children and Adolescents

Condition(s) studied

Investigational drug(s) / intervention(s)

Positive airway pressure therapy: Initiation of continuous or bilevel positive airway pressure therapy

Study summary

Positive Airway Pressure (PAP) is a treatment used to help people with sleep-disordered breathing, particularly those with obstructive sleep apnea (OSA). The device delivers pressurized air through a mask to keep the airways open during sleep, improving breathing and preventing interruptions in sleep.

Studying how insomnia affects PAP adherence in children can help improve future treatments.

However, no long-term studies have looked at this in children. Based on previous research, the investigators plan to conduct a study across multiple centers focusing on children with OSA starting PAP therapy. The study will explore how insomnia affects PAP adherence and how race and ethnicity play a role.

Eligibility

Primary outcome measure(s)

• Mean minutes of nightly PAP usage — 90 days
  Adherence will be determined objectively using ventilator download data (days 60-90 after PAP initiation)

Trial sites (1)

More Lena Xiao trials in Canada

Other trials for the same condition